Kythera Biopharmaceuticals

company

About

Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$30M
Industries
Biopharma,Biotechnology,Health Care
Founded date
Aug 1, 2005
Number Of Employee
101 - 250
Operating Status
Active

KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California.

KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$98.40M
Kythera Biopharmaceuticals has raised a total of $98.40M in funding over 2 rounds. Their latest funding was raised on Sep 19, 2011 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 19, 2011 Series D $37.40M 3 Foley Ventures Detail
May 19, 2008 Series C $30M 4 Jafco Life Science Detail
Jul 24, 2006 Series B $30M 2 Detail
Sep 16, 2005 Seed $1M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
3
5
Kythera Biopharmaceuticals is funded by 5 investors. Foley Ventures and Jafco Life Science are the most recent investors.
Investor Name Lead Investor Funding Round
Foley Ventures Yes Series D
Jafco Life Science Yes Series C
ARCH Venture Partners Series D
Versant Ventures Series D
Apothecary Capital Series C